U.S. Dialysis Service Market Updates

U.S. Dialysis Service Market size was valued at USD 27.03 Billion in 2023 and is poised to grow from USD 27.87 Billion in 2024 to USD 35.57 Billion by 2032, growing at a CAGR of 3.11% during the forecast period (2025-2032).

Manufacturers of dialysis equipment are concentrating on enhancing their market position through strategic alliances and agreements. Companies are enhancing their product ranges and increasing their global reach as a result of the creation of new platforms. 'DaVita Inc.', 'Fresenius Medical Care AG & Co. KGaA', 'U.S. Renal Care, Inc.', 'American Renal Associates Holdings, Inc.', 'Satellite Healthcare, Inc.', 'Dialysis Clinic, Inc.', 'Quik Travel Staffing', 'DSI Renal, Inc.', 'Total Renal Care, Inc.', 'Northwest Kidney Centers', 'Renal Ventures Management LLC', 'RAI Care Centers', 'Liberty Dialysis Holdings, Inc.', 'Atlantic Dialysis Management Services', 'Bio-Medical Applications of Florida, Inc.', 'ARA Dialysis Centers, LLC', 'NxStage Medical, Inc.', 'Caring Dialysis, LLC', 'Midwest Dialysis Centers', 'Central Dialysis Center'

Home hemodialysis may be more advantageous than a clinic or hospital treatment. Patients have the option of lengthier and more frequent sessions. The use of home healthcare services enables hospitals to serve a rising number of patients. For instance, DaVita and Fresenius Medical Care provide two classes: peritoneal and hemodialysis, the latter of which requires a machine and particular filter and is quite similar to what is provided in clinics.

Both telehealth and dialysis encourage more in-home treatment, less time, and fewer clinic visits. Additionally, it aids in patient education regarding self-care and home methods. To offer care to patients getting treatment, nephrologists and dialysis providers have used telehealth systems.

Owing to high availability of facilities, the Southeast region held a notable market share in 2021. Alabama and Georgia have the largest percentage of service providers per patient, with 13.07-17.50 facilities per 1000 ESRD patients, according to the CDC. The region has a higher overall prevalence of end-stage renal disease. According to the CDC, Alabama has a 4% prevalence of ESRD compared to a national prevalence of 2.9%, making it one of the highest reported in the country.